Skip to content
Dose Brief
Menu
No. 287 here · Grade C

Kin Meds review

Kin Meds is a LegitScript-verified telehealth platform offering both compounded GLP-1s (semaglutide from $199/mo, tirzepatide from $249/mo) and brand-name FDA-approved options.

Visit Kin Meds Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.

On the record

The FDA issued a warning letter to Kin Meds in February 2026. Kin Meds keeps its place here and its link is unchanged — but you should know the letter exists before you start care. Read it in the FDA's warning letter database.

Semaglutide
From $149/mo (brand Wegovy)
Tirzepatide
From $149/mo (brand Zepbound)
Coverage
Coverage not published
Brand-name
Yes

Prices read from Kin Meds's own site on . Providers change pricing without notice — check the current figure before you buy.

On the trackerNewnew to the tracker, no prior reading— New to the tracker on 1 August 2026. The published line reads From $149/mo (brand Wegovy) at our first reading; there is no earlier reading of ours to compare it against yet.

The scorecard

Kin Meds scored on our six Brief Score factors. See the methodology.

Price Stability48/100
Supply Reliability78/100
Transparency72/100
Access Breadth62/100
Clinical Oversight74/100
Track Record51/100

What we like

  • Publicly lists $199/mo compounded semaglutide and $249/mo compounded tirzepatide
  • Brand-name options too — Wegovy injection and pill, Zepbound, Foundayo from $149/mo entry pricing
  • LegitScript verified
  • Clearly identifies itself as the intake platform and a licensed third-party pharmacy as the dispenser
  • Broad longevity menu (Sermorelin, NAD+, Glutathione) plus TRT, hair, skin, and sexual health

The caveats

  • Legal entity name and state of incorporation not publicly disclosed
  • The third-party pharmacy partner isn't named, and Kin Meds isn't itself a licensed pharmacy
  • Per-state availability not listed
  • $149/mo brand pricing is the insured entry tier — cash-pay patients should expect higher real costs
  • FDA issued Kin Meds a warning letter in February 2026; the letter is public in FDA's warning-letter database

The brief

Best for: Readers who want compounded and brand-name GLP-1 plus a longevity stack on one platform. Kin Meds is a LegitScript-verified telehealth platform offering both compounded GLP-1s (semaglutide from $199/mo, tirzepatide from $249/mo) and brand-name FDA-approved options.

Ranked #287 of 546 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Before you decide

The questions readers ask next after reading about Kin Meds.

Closest here

The providers scoring nearest Kin Meds — the realistic shortlist if you're weighing it.

Weighing Kin Meds against one provider in particular? There is a full head-to-head with our top-ranked pick in CoreAge Rx vs Kin Meds, and every provider that outranks it is listed on the Kin Meds alternatives ranking.

More providers we track (24)

515 more are filed too — see every provider we track, ranked.

Pricing, states and verification reflect Kin Meds's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on Kin Meds's site. Not medical advice; see our disclosure.

← Back to all rankings